Publication:
Part 2: Making the "unproven" "proven".

dc.contributor.authorWeiss, Daniel J
dc.contributor.authorRasko, John E J
dc.contributor.authorCuende, Natividad
dc.contributor.authorRuiz, Milton A
dc.contributor.authorHo, Hong-Nerng
dc.contributor.authorNordon, Robert
dc.contributor.authorWilton, Steve
dc.contributor.authorDominici, Massimo
dc.contributor.authorSrivastava, Alok
dc.date.accessioned2023-01-25T08:30:30Z
dc.date.available2023-01-25T08:30:30Z
dc.date.issued2016
dc.identifier.doi10.1016/j.jcyt.2015.11.005
dc.identifier.essn1477-2566
dc.identifier.pmid26719203
dc.identifier.unpaywallURLhttps://iris.unimore.it/bitstream/11380/1117728/1/Part.2.pdf
dc.identifier.urihttp://hdl.handle.net/10668/9693
dc.issue.number1
dc.journal.titleCytotherapy
dc.journal.titleabbreviationCytotherapy
dc.language.isoen
dc.organizationFundación Pública Andaluz Progreso y Salud-FPS
dc.page.number120-3
dc.pubmedtypeJournal Article
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titlePart 2: Making the "unproven" "proven".
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number18
dspace.entity.typePublication

Files